MedImmune confirms $6.5 million research deal with Johns Hopkins

12/13/2013 | Genetic Engineering & Biotechnology News

Baltimore-based Johns Hopkins University has signed a deal with AstraZeneca's research and development arm MedImmune to collaborate on research projects in cancer; respiratory conditions, inflammation and autoimmunity; infectious disease; antibody development and protein engineering.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ